Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (OTCQB:TPIV)

0.575
Delayed Data
As of May 27
 -0.005 / -0.86%
Today’s Change
0.24
Today|||52-Week Range
1.71
-4.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses5.5M2.7M3.4M6.2M
 
 
 
 
 
Research And Development1.1M661.6K189.0K1.7M
 
 
 
 
 
Total Operating Expenses5.5M2.7M3.4M6.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.5M-2.7M-3.4M-6.2M
 
 
 
 
 
Extraordinary Credit536.5K1.5M581.000.00
 
 
 
 
Extraordinary Charge-163.8K-2.7M-26.9M-27.9M
 
 
 
 
 
Interest Expense On Debt745.1K1.8M575.5K10.9K
 
 
 
 
 
Other Expenses-7.9K5.9K-53.0K775.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.9M-5.5M-30.9M-34.1M
 
 
 
 
 
Net Income-5.9M-5.5M-30.9M-34.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS655.3K1.1M15.5M43.9M
 
 
 
 
 
Shares To Calculate EPS Diluted655.3K1.1M15.5M43.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.00-$4.87-$2.00-$0.78
 
 
 
 
 
EPS Diluted-$9.00-$4.87-$2.00-$0.78